Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Adastra Holdings Ltd
(OP:
XTXXF
)
0.0126
UNCHANGED
Last Price
Updated: 2:13 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Adastra Holdings Ltd
Canadian Cannabis Concentrates Producer, Adastra, Reports Third Year Of Record Revenue, But Also Higher Losses
April 25, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From August 24, 2023
August 24, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Adastra Holdings Appoints Smoke Wallin As New Director
May 16, 2022
Adastra Holdings Ltd. (OTCPK: XTXXF) (FRA: D2EP) appointed Smoke Wallin to the company's board of directors. Wallin Responds
Via
Benzinga
Canadian Marijuana Stock Posts 133% YoY Revenue Growth, But Also 124% Higher Net Loss In Q2
August 18, 2023
Candian marijuana operator Adastra Holdings Ltd. (OTC: XTXXF)(CSE:XTRX)(FRA:D2EP) reported Thursday financial results for the three months ended June 30, 2023, disclosing net revenue of CA$7.1 million,...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Canadian Weed Company Adastra Reports Triple-Digit Q1 Revenue Growth, What's Behind The Figures?
May 31, 2023
Cannabis producer Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) (OTC: XTXXF) reported on Tuesday financial results for the three months ended March 31, 2023.
Via
Benzinga
Adastra FY22 Revenue Grows 136%, Here Is What You Need To Know
May 02, 2023
Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX)(FRA:D2EP) FY 2022 net revenue increased 136% to CA$13.3 million ($9.8 million), compared to CA$5.6 million in FY 2021. FY 2022 Financial Highlights Gross...
Via
Benzinga
Adastra Stock Skyrockets On Record Shipment Volume, Following The News Of Civil Lawsuit
March 16, 2023
Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX)(FRA:D2EP) has been served with a civil claim filed in the Supreme Court of British Columbia pursuant to the Class Proceedings Act, R.S.B.C. 1996, c. 50...
Via
Benzinga
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
March 13, 2023
Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial
Via
Benzinga
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
March 07, 2023
Psychedelics Bills Around The Country: 9 New Proposals, Several Passes, Several Fails And A Successful Local Decriminalization Throughout the 2023 session, numerous discussions have been...
Via
Benzinga
Adastra Clarifies Health Canada Approval To Handle Cocaine
March 06, 2023
Adastra Labs Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) provided clarification regarding its receipt of Health Canada approval for the amendment to include cocaine under its controlled substances...
Via
Benzinga
Canadian Weed Company's Plan To Produce Cocaine Shocks Local Leader, Opposition Questions Drug Experiment
March 03, 2023
A Langley, British Columbia, cannabis company got the green light from Health Canada to produce and sell cocaine earlier this month, but the province's Premier says he was unaware of the mo
Via
Benzinga
Canada Gives This Cannabis Company The Green Light To Handle Cocaine, Psilocybin
February 23, 2023
Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) (OTCPK: XTXXF) reported on Wednesday that Adastra Labs got the green light from Health Canada earlier this month for its amendment to include cocaine as a...
Via
Benzinga
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
December 06, 2022
Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and...
Via
Benzinga
Adastra Q3 Revenue Grows 110% YoY To $2.83M
December 02, 2022
Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX)(FRA:D2EP), released its financial results for the three and nine months ended September 30, 2022. Q3 2022 Financial Highlights
Via
Benzinga
Adastra Steps Into Magic Mushrooms! Gets Dealer's License For Psilocybin And Psilocin
August 31, 2022
Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) has received its Controlled Drug and Substances Dealer's License on August 24, 2022. This license allows Adastra to process psilocybin and...
Via
Benzinga
Cannabis Movers & Shakers: OnPoint Laboratories, Neptune Wellness, Adastra Holdings & Cannaverse Technologies
May 20, 2022
OnPoint Laboratories Names Samuel Richard CEO & Equity Partner OnPoint Laboratories has appointed Samuel Richard to serve as CEO and equity partner. Richard succeeds Jeff Cardot, founder and current...
Via
Benzinga
Adastra Holdings Reports Record Revenue In 2021, Here Are The Details
May 04, 2022
Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) has filed its consolidated financial statements and related management discussion and analysis for the year ended December 31, 2021.
Via
Benzinga
Adastra Submits Medical Sales License Application And Engages IR Labs To Provide Investor Relations Services
April 11, 2022
Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) submitted medical sales license application to Health Canada on April 1, 2022. A medical sales license would permit Adastra to perform the...
Via
Benzinga
Adastra Holdings Approved For Dealer's License For Psilocybin, Psilocin, MDMA, DMT, 5-MeO-DMT & LSD
March 25, 2022
Adastra Holdings Ltd. (OTCPK: XTXXF) (CSE:XTRX) (FRA:...
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.